Literature DB >> 7264325

Large-scale purification and cryopreservation of human monocytes.

M De Boer, R Reijneke, R J Van de Griend, J A Loos, D Roos.   

Abstract

Human blood monocytes were purified by a new method capable of handling 3 X 10(9) mononuclear leukocytes, which does not involve adherence of the cells and takes about 3 h to perform. The yield of monocytes is 70%, the purity about 90% and the viability 99%. Monocytes purified by this method were cryopreserved at -196 degrees C. The function of the cells was tested before freezing and after thawing. We found that the capacity of cryo-preserved monocytes to move to the source of a chemotactic gradient, to ingest particles, to mount a respiratory burst during phagocytosis, to kill intracellular bacteria, to lyse anti-D sensitized erythrocytes and to help autologous lymphocytes in a proliferative response to mitogens or antigens, was preserved by 70% or more as compared with non-frozen cells. Thus, cryopreservation of human blood monocytes is possible with maintenance of functional capacities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7264325     DOI: 10.1016/0022-1759(81)90027-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

Review 1.  Cryopreserved normal macrophages as a control for assays of macrophage function.

Authors:  L S Lamb; J B Willoughby; W F Willoughby
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-02       Impact factor: 2.416

2.  Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3.

Authors:  W van Eden; B G Elferink; R R de Vries; D L Leiker; J J van Rood
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

3.  Significance of low molecular weight C1q in systemic lupus erythematosus.

Authors:  R Hoekzema; A J Swaak; M C Brouwer; A van Rooijen; E J Nieuwenhuys; C E Hack
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

4.  Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors.

Authors:  R H See; A W Chow
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

5.  Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes.

Authors:  R H See; W W Kum; A H Chang; S H Goh; A W Chow
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.

Authors:  P J Voogt; E Goulmy; W E Fibbe; W F Veenhof; A Brand; J H Falkenburg
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Role of the adhesion molecule lymphocyte function associated antigen 1 in toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human monocytes.

Authors:  R H See; A W Chow
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Isolation and partial characterization of a novel subset of human T lymphocytes defined by monoclonal antibodies.

Authors:  R J Van de Griend; H G De Bruin; H C Rümke; R Van Doorn; D Roos; A Astaldi
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

9.  Biosynthesis of normal and low-molecular-mass complement component C1q by cultured human monocytes and macrophages.

Authors:  R Hoekzema; M C Brouwer; E R de Graeff-Meeder; H P van Helden; C E Hack
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

10.  Functional activity of enucleated human polymorphonuclear leukocytes.

Authors:  D Roos; A A Voetman; L J Meerhof
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.